Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

詳細記述

書誌詳細

主要な著者:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2026-03-01
シリーズ:	JEADV Clinical Practice
主題:	atopic dermatitis biologics JAK inhibitors real‐world evidence
オンライン･アクセス:	https://doi.org/10.1002/jvc2.70153
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!